Form 4 for CRBU Caribou Biosciences, Inc.
Accepted 2022-08-26 00:00:00 ET · period of report 2022-08-25 · accession 0001209191-22-047748 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-26 | 2022-08-25 | CRBU | Kanner Steven | CSO | S - Sale+OE | $11.22 | -43.2K | 302.1K | -13% | -$485.2K |
| D | 2022-08-26 | 2022-08-25 | CRBU | Kanner Steven | CSO | M - OptEx | $2.69 | +43.2K | 345.3K | +14% | +$116.3K |
| D | 2022-08-26 | 2022-08-25 | CRBU | Kanner Steven | CSO | M - OptEx | $0.00 | -43.2K | 73.6K | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-25 | S | D | 43,248 | $11.22 | 302,059 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.88 to $11.37, inclusive. The reporting person undertakes to provide to Caribou Biosciences, Inc., any security holder of Caribou Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. |
| 2 | Common | Common Stock | 2022-08-25 | M | A | 43,248 | $2.69 | 345,307 | D | — | — | |
| 3 | Derivative | Option to purchase Common Stock | 2022-08-25 | M | D | 43,248 | $0.00 | 73,601 | D | $2.69 · — to 2029-09-30 | 43,248 Common Stock | (F3) 1/4th of the shares subject to this option vested on October 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. |